Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia

BMJ Open Respiratory Research

Volumn 1, Issue 1, 2014, Pages

  Dwyer, Richard ^a   Hedlund, Jonas ^a   Henriques Normark, Birgitta ^a   Kalin, Mats ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD OXYGENATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COMMUNITY ACQUIRED PNEUMONIA; CRB 65 SCORE; FEMALE; HOSPITALIZATION; HUMAN; HYPOXEMIA; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE RESEARCH; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 85006662273     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2014-000038     Document Type: Article

References (39)

1. Woodhead MA, Macfarlane JT, McCracken JS, et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671–4.
2. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137:977–88.
3. Foy HM, Conney MK, Allan I, et al. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA 1979;241:253–8.
4. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501–13.
5. Myint PK, Kwok CS, Majumdar SR, et al. The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale design and description of study cohorts and patients. BMJ Open 2012;2:1–13.
6. Pneumonia. European lung white book. 2nd edn. Sheffield, UK: European Respirator Society/European Lung Foundation, 2003:55–65.
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–50.
8. Lim WS, Macfarlane JT, Boswell TC, et al. Study of communityacquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001;56:296–301.
9. Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–82.
10. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):iii1–55.
11. Shindo Y, Sato S, Maruyama E, et al. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 2008;13:731–5.
12. Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008;47:375–84.
13. Yandiola PP, Capelastegui A, Quintana J, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 2009;135:1572–9.
14. Feldman C, Alanee S, Yu VL, et al. Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care. Clin Microbiol Infect 2009;15:850–7.
15. Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 2004;59:421–7.
16. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998;158:1102–8.
17. Spindler C, Ortqvist A. Prognostic score systems and communityacquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006;28:816–23.
18. Fine MJ, Medsger AR, Stone RA, et al. The hospital discharge decision for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 1997;157:47–56.
19. Dwyer R, Hedlund J, Darenberg J, et al. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia. Scand J Infect Dis 2011;43:448–55.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two more or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837–45.
21. Coley CM, Li YH, Medsger AR, et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med 1996;156:1565–71.
22. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347–82.
23. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005;118:384–92.
24. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–72.
25. Bauer TT, Ewig S, Marre R, et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006;260:93–101.
26. Loke YK, Kwok CS, Niruban A, et al. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 2010;65:884–90.
27. Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010;65:878–83.
28. Spindler C, Strålin K, Eriksson L, et al. Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults-Swedish Society of Infectious Diseases 2012. Scand J Infect Dis 2012;44:885–902.
29. Levy ML, Le Jeune I, Woodhead MA, et al. British Thoracic Society Community-Acquired Pneumonia in Adults Guideline G. Primary care summary of the British Thoracic Society Guidelines for the management of community-acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK. Prim Care Respir J 2010;19:21–7.
30. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134–41.
31. Bordon J, Peyrani P, Brock GN, et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008;133:618–24.
32. McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810–15.
33. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005;127:1260–70.
34. Neill AM, Martin IR, Weir R, et al. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010–16.
35. Ortqvist A, Hedlund J, Grillner L, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990;3:1105–13.
36. Jones JS, Neff TL, Carlson SA. Use of the alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Am J Emerg Med 1998;16:333–7.
37. Bewick T, Greenwood S, Lim WS. What is the role of pulse oximetry in the assessment of patients with community-acquired pneumonia in primary care? Prim Care Respir J 2010;19:378–82.
38. Buising KL, Thursky KA, Black JF, et al. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007;19:418–26.
39. Myint PK, Kamath AV, Vowler SL, et al. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35:286–91.